BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 28848053)

  • 21. Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.
    Liu H; Zhang T; Ye J; Li H; Huang J; Li X; Wu B; Huang X; Hou J
    Cancer Immunol Immunother; 2012 Oct; 61(10):1849-56. PubMed ID: 22456757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells.
    Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ
    Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD4+CXCR4highCD69+ T cells accumulate in lung adenocarcinoma.
    Wald O; Izhar U; Amir G; Avniel S; Bar-Shavit Y; Wald H; Weiss ID; Galun E; Peled A
    J Immunol; 2006 Nov; 177(10):6983-90. PubMed ID: 17082613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine biosynthesis by tumor-infiltrating T lymphocytes from human non-small-cell lung carcinoma.
    Ortegel JW; Staren ED; Faber LP; Warren WH; Braun DP
    Cancer Immunol Immunother; 2000 Feb; 48(11):627-34. PubMed ID: 10663610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Killing of laminin receptor-positive human lung cancers by tumor infiltrating lymphocytes bearing gammadelta(+) t-cell receptors.
    Ferrarini M; Heltai S; Pupa SM; Mernard S; Zocchi R
    J Natl Cancer Inst; 1996 Apr; 88(7):436-41. PubMed ID: 8618235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
    Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
    Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumour-infiltrating lymphocytes in non-small cell lung cancer are activated T lymphocytes.
    Kuo SH; Chang DB; Lee YC; Lee YT; Luh KT
    Respirology; 1998 Mar; 3(1):55-9. PubMed ID: 9657662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial Architecture and Arrangement of Tumor-Infiltrating Lymphocytes for Predicting Likelihood of Recurrence in Early-Stage Non-Small Cell Lung Cancer.
    Corredor G; Wang X; Zhou Y; Lu C; Fu P; Syrigos K; Rimm DL; Yang M; Romero E; Schalper KA; Velcheti V; Madabhushi A
    Clin Cancer Res; 2019 Mar; 25(5):1526-1534. PubMed ID: 30201760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients.
    Petersen RP; Campa MJ; Sperlazza J; Conlon D; Joshi MB; Harpole DH; Patz EF
    Cancer; 2006 Dec; 107(12):2866-72. PubMed ID: 17099880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis.
    Zhuang X; Xia X; Wang C; Gao F; Shan N; Zhang L; Zhang L
    Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):24-8. PubMed ID: 19713832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4
    Mastracci L; Fontana V; Queirolo P; Carosio R; Grillo F; Morabito A; Banelli B; Tanda E; Boutros A; Dozin B; Gualco M; Salvi S; Romani M; Spagnolo F; Poggi A; Pistillo MP
    Cancer Immunol Immunother; 2020 Apr; 69(4):653-662. PubMed ID: 32025849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer.
    Shimizu K; Nakata M; Hirami Y; Yukawa T; Maeda A; Tanemoto K
    J Thorac Oncol; 2010 May; 5(5):585-90. PubMed ID: 20234320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
    Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
    Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma.
    Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH
    Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of tumor-infiltrating lymphocyte cytolytic activity against human non-small cell lung cancer.
    Ortegel JW; Staren ED; Faber LP; Warren WH; Braun DP
    Lung Cancer; 2002 Apr; 36(1):17-25. PubMed ID: 11891029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human CD4+ effector memory T cells persisting in the microenvironment of lung cancer xenografts are activated by local delivery of IL-12 to proliferate, produce IFN-gamma, and eradicate tumor cells.
    Broderick L; Yokota SJ; Reineke J; Mathiowitz E; Stewart CC; Barcos M; Kelleher RJ; Bankert RB
    J Immunol; 2005 Jan; 174(2):898-906. PubMed ID: 15634912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of oligoclonal T lymphocytes in lymph nodes draining from advanced non-small-cell lung cancer.
    Meta M; Ponte M; Guastella M; Semino C; Pietra G; Ratto GB; Melioli G
    Cancer Immunol Immunother; 1995 Apr; 40(4):235-40. PubMed ID: 7750121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytes.
    Ye Q; Loisiou M; Levine BL; Suhoski MM; Riley JL; June CH; Coukos G; Powell DJ
    J Transl Med; 2011 Aug; 9():131. PubMed ID: 21827675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variance of TNFAIP8 expression between tumor tissues and tumor-infiltrating CD4+ and CD8+ T cells in non-small cell lung cancer.
    Wang L; Song Y; Men X
    Tumour Biol; 2014 Mar; 35(3):2319-25. PubMed ID: 24136748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.